---
title: "微创医疗科学有限公司 (00853.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/00853.HK.md"
symbol: "00853.HK"
name: "微创医疗科学有限公司"
industry: "医疗器械"
---

# 微创医疗科学有限公司 (00853.HK)

| Item | Detail |
|------|--------|
| Industry | 医疗器械 |
| Location | 港股市场 |
| Website | [www.microport.com](https://www.microport.com) |

## Company Profile

微创医疗科学有限公司是一家主要从事医疗器械的销售、生产、研究及开发 (R&D) 的投资控股公司。该公司通过八个分部开展业务。心血管介入业务分部包括植入器械、通路器械等产品。骨科医疗器械业务分部包括关节重建、脊柱等器械。心律管理 (CRM) 业务分部包括起搏器、除颤器等器械。大动脉及外周血管介入业务分部包括 “L-REBOA” 主动脉阻断球囊等产品。神经介入业务分部包括脑动脉粥样硬化狭窄、弹簧圈等产品。结构性心脏病业务分部包括经导管主动脉瓣植入术等产品。手术机器人业务分部从事手术机器人器械的制造及研发。外科医疗器械业务分部从事外科医疗器械的制造及研发。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-15T04:30:11.000Z

**Overall: D (0.69)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 22 / 26 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -1.03% |  |
| Net Profit YoY | 60.36% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 4.43 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 21.64B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 7.94B |  |


**Multi Score**: D

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -24.77% | E |
| Profit Margin | -16.06% | D |
| Gross Margin | 56.36% | B |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -1.03% | D |
| Net Profit YoY | 60.36% | B |
| Total Assets YoY | -0.07% | D |
| Net Assets YoY | -7.80% | D |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -622.59% | E |
| OCF YoY | -1.03% | D |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.27 | D |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 68.71% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 微创医疗科学有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-24.77%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-16.06%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "56.36%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-1.03%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "60.36%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.07%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-7.80%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-622.59%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-1.03%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.27",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "68.71%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 时代天使 (HK.6699) | B | A | C | B | B | B |
| 02 | 归创通桥 (HK.2190) | B | A | D | A | B | B |
| 03 | 爱康医疗 (HK.1789) | B | A | C | B | B | B |
| 04 | 心泰医疗 (HK.2291) | A | A | D | A | B | B |
| 05 | 现代牙科 (HK.3600) | A | B | B | B | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -16.83 | 22/27 | - | - | - |
| PB | 4.43 | 24/27 | 5.08 | 4.22 | 2.82 |
| PS (TTM) | 2.70 | 7/27 | 3.06 | 2.58 | 1.78 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-22T16:00:00.000Z

Total Analysts: **8**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 4 | 50% |
| Overweight | 1 | 13% |
| Hold | 2 | 25% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 11.29 |
| Highest Target | 18.23 |
| Lowest Target | 8.81 |

## References

- [Company Overview](https://longbridge.com/en/quote/00853.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/00853.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/00853.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.